Skip to main content
EJNMMI Radiopharmacy and Chemistry
Fig. 6 | EJNMMI Radiopharmacy and Chemistry

Fig. 6

From: Optimizing labelling conditions of 213Bi-DOTATATE for preclinical applications of peptide receptor targeted alpha therapy

Fig. 6

Survival (%) ± SD of CA20948 after exposure to the compounds used in standard labelling procedure, n = 3. Concentration in incubation medium was; [TRIS] = 16 mmol.L−1, [AA] = ascorbic acid, 3.4 mmol.L−1, [NaI] = 3.6 mmol.L−1, [HCl] = 3.6 mmol.L−1 and [DTPA] = 6.1 × 10−3 mmol.L−1

Back to article page